Evidence map›Paper›PMID 31288541›Full record

ArticleEuropean journal of preventive cardiology2020

Associations of blood pressure categories defined by 2017 ACC/AHA guidelines with mortality in China: Pooled results from three prospective cohorts.

Na Liu, Jae Jeong Yang, Ruiwei Meng, Xiong-Fei Pan, Xiaomin Zhang, Meian He, Honglan Li, Yu-Tang Gao, Yong-Bing Xiang, Xiao-Ou Shu and 4 more

Open access · greenAbstract read
In one paragraph

Article in European journal of preventive cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. 2024 Thai guidelines on the treatment of hypertension.Asian biomedicine : research, reviews and news · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Na LiuDepartment of Nutrition and Food Hygiene, Huazhong University of Science and Technology, China.
Jae Jeong YangVanderbilt Epidemiology Center, Vanderbilt University Medical Center, USA.
Ruiwei MengDepartment of Epidemiology and Biostatistics, Huazhong University of Science and Technology, China.
Xiong-Fei PanDepartment of Epidemiology and Biostatistics, Huazhong University of Science and Technology, China.
Xiaomin ZhangDepartment of Occupational and Environmental Health, Huazhong University of Science and Technology, China.
Meian HeDepartment of Occupational and Environmental Health, Huazhong University of Science and Technology, China.
Honglan LiState Key Laboratory of Oncogene and Related Genes and Department of Epidemiology, Shanghai Jiaotong University School of Medicine, China.
Yu-Tang GaoState Key Laboratory of Oncogene and Related Genes and Department of Epidemiology, Shanghai Jiaotong University School of Medicine, China.
Yong-Bing XiangState Key Laboratory of Oncogene and Related Genes and Department of Epidemiology, Shanghai Jiaotong University School of Medicine, China.
Xiao-Ou ShuVanderbilt Epidemiology Center, Vanderbilt University Medical Center, USA.
Wei ZhengVanderbilt Epidemiology Center, Vanderbilt University Medical Center, USA.
Tangchun WuDepartment of Occupational and Environmental Health, Huazhong University of Science and Technology, China.
Danxia YuVanderbilt Epidemiology Center, Vanderbilt University Medical Center, USA.
An PanDepartment of Epidemiology and Biostatistics, Huazhong University of Science and Technology, China.
Huazhong University of Science and Technology · CNVanderbilt University Medical Center · USState Key Laboratory of Oncogene and Related Genes · CNNanjing Medical University · CN

Funding

Cohort Study of Cancer inhibitory Factors in MenR01CA082729 · NCI · VANDERBILT UNIVERSITY · PI SHU, XIAO-OU · 2001 to 2011
$6.3M
Shanghai Womens Health StudyUM1CA182910 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2014 to 2018
$5.9M
Shanghai Men's Health StudyUM1CA173640 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHU, XIAO-OU · 2013 to 2017
$4.9M
Cancer Risk Reduction and Diet: A Cohort Study of WomenR37CA070867 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZHENG, WEI · 2009 to 2013
$4.7M
NCI NIH HHS R01 CA082729NCI NIH HHS R37 CA070867NCI NIH HHS UM1 CA173640NCI NIH HHS UM1 CA182910
6 · The paper itself

Abstract

backgroundThe recent American College of Cardiology/American Heart Association guidelines for high blood pressure lowered the hypertension criteria from systolic/diastolic blood pressure (SBP/DBP) of 140/90 mmHg or greater to 130/80 mmHg or greater, while the potential impact of the change on Chinese adults remains unclear.

designA pooled prospective cohort analysis.

methodsIncluded were 154,407 Chinese adults from three prospective cohorts, which measured blood pressure at baseline and follow-up visits, and tracked death events by linkages to medical insurance system or vital statistics registries. Cox regression models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs).

resultsDuring a total follow-up of 1,718,089 person-years, 14,692 deaths were documented including 5086 cardiovascular deaths (1277 ischaemic heart disease and 2509 cerebrovascular disease deaths). Compared to normal blood pressure (SBP/DBP < 120/80 mmHg), newly defined stage 1 hypertension (SBP/DBP 130-139/80-89 mmHg) was associated with increased cardiovascular mortality (HR 1.40, 95% CI 1.16-1.69; HR 1.36, 95% CI 1.12-1.65 for ischaemic heart disease mortality; HR 1.53, 95% CI 1.18-2.00 for cerebrovascular mortality), but not with all-cause mortality (HR 1.04, 95% CI 0.89-1.21). Stage 2 hypertension (SBP/DBP ≥ 140/90 mmHg) showed significant associations with cardiovascular disease and all-cause mortality, while elevated blood pressure (SBP 120-129 mmHg and DBP < 80 mmHg) showed null associations. The associations were stronger in adults younger than 65 years and adults without pre-existing cardiovascular disease compared with their counterparts (

conclusionsThe newly defined stage 1 hypertension is associated with an increased risk of cardiovascular disease mortality in the Chinese population, particularly among younger adults and those without a history of cardiovascular disease.

Indexed as

Blood PressureAdultAgedBlood Pressure DeterminationCause of DeathChinaFemaleHeart Disease Risk FactorsHumansHypertensionMaleMiddle AgedPractice Guidelines as TopicPredictive Value of TestsPrevalencePrognosisBlood pressurecardiovascular diseaseChinesecohort studyhypertensionmortality

Identifiers

PMID31288541
PMCPMC8040133
OpenAlexW2957490782

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.